Mrs Kim LauperMD

View graph of relations

Overview

Following the completion of her MD and specialisation in rheumatology in Geneva, Switzerland, Kim Lauper moved to the UK as a clinical research fellow in the Arthritis Research UK Centre of Epidemiology and PhD student at the University of Manchester.
Her PhD will focus on the real-life use of a biologic treatment for rheumatoid arthritis, tocilizumab, using register data.

Qualifications

  • Doctorate of Medicine, University of Geneva (2018)
  • Specialisation in Internal Medicine (2014) and Rheumatology (2018) awarded by the Swiss Medical Association (FMH)
  • Musculoskeletal Ultrasound Training (2017) awarded by the Swiss Society of Ultrasonography (SGUM)
  • Certificate of Advanced Studies in Patients-oriented Clinical Research, University of Geneva (2018)
  • Diploma of Medicine, University of Geneva (2009)

Memberships of committees and professional bodies

  • 2018-now Member of the EMEUNET working group (group undertaking the organisational role to facilitate the wider aims of EMEUNET and represents the EMEUNET Community, European group of young rheumatology researchers and clinicians), peer-mentoring subgroup
  • 2018-now Member of the American College of Rheumatology
  • 2017-now Member of AMIG’s committee (Association of Institutional Physicians of Geneva)
  • 2015-now Member of EMEUNET (the emerging EULAR – European League Against Rheumatism – network, European group of young rheumatology researchers and clinicians)
  • 2009-now Member of FMH (Swiss medical association) and ASMAC (Swiss association for medical interns and senior registrars)
  • 2004-2006 Member of GRAC junior (Groupe de recherche en anatomie clinique, Prof. J. Fasel)
  • 2002-2009 Member of the Geneva medical student association (AEMG)






Keywords

  • Rheumatoid arthritis, Observational studies, Effectiveness, Safety, Methodology, Cardiovascular diseases

Related information